AS
Alicia Secor
Director

Alicia Secor insider trades: Gw Pharmaceuticals (GWPH) stock buys and sales

Director, Gw Pharmaceuticals Last trade Mar 2, 2020 33 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
6
Open-market trades
since 2014
7
Companies
last trade 2020

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Alicia reports to the SEC

and 1 more company

Open-market buys and sales

6 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 2, 2020GWPH↓ Sell$11K
Jan 3, 2020GWPH↓ Sell$13K
Mar 13, 2019GWPH↓ Sell$13K
Aug 25, 2016JNP↑ Buy$29K
Sep 17, 2015ZFGN↓ Sell10b5-1$1.1M
Jun 19, 2014ZFGN↑ Buy$80K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Alicia Secor's insider trades

Alicia Secor is a director at Gw Pharmaceuticals (GWPH). Since Jun 19, 2014, Alicia has reported 2 open-market purchases worth $109K and 4 sales worth $1.1M on SEC Form 4. There have been no open-market trades in the last 12 months.

1 sale (97% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.

Their filings also include grants and awards (19 filings), shares returned to the company (4 filings), option exercises (4 filings), shares withheld for taxes (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GWPH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.